Cargando…

Clinical Application of Inferior Alveolar Nerve Block Device for Safe and Secure IANB by Any Operator

The inferior alveolar nerve block (IANB) is an established technique with a success rate of 60–80%; however, large errors have been reported among operators. Some dentists do not prefer to use IANB because of the risk of complications. Nevertheless, it is a useful technique for pain control, and a s...

Descripción completa

Detalles Bibliográficos
Autores principales: Noguchi, Tomoyasu, Odaka, Kento, Fukuda, Ken-ichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504047/
https://www.ncbi.nlm.nih.gov/pubmed/37719895
http://dx.doi.org/10.1155/2023/1021918
_version_ 1785106642023481344
author Noguchi, Tomoyasu
Odaka, Kento
Fukuda, Ken-ichi
author_facet Noguchi, Tomoyasu
Odaka, Kento
Fukuda, Ken-ichi
author_sort Noguchi, Tomoyasu
collection PubMed
description The inferior alveolar nerve block (IANB) is an established technique with a success rate of 60–80%; however, large errors have been reported among operators. Some dentists do not prefer to use IANB because of the risk of complications. Nevertheless, it is a useful technique for pain control, and a secure IANB offers significant benefits to operators and patients. This case series study aimed to investigate the efficacy of the “IANB Device,” a nerve block guide for IANB, and the adverse events associated with its use in clinical practice. IANB was performed using the device on five patients who had undergone detailed computed tomography examination for chronic orofacial pain in the third division of the trigeminal nerve. Lidocaine 1% (1 mL, no adrenaline added) was used as the local anesthetic. IANB was performed by three dentists with 2, 5, and 11 years of experience in orofacial pain treatment. Thus, the data were collected in triplicate for each patient. The primary endpoints were whether adjustment of the IANB device was required, changes in the sensation threshold of the lower lip, the time to disappearance of pain, the presence or absence of tongue sensation (“Do you have numbness in your tongue?”: “Yes/No”), and discomfort (visual analog scale). The incidence of any other adverse events was recorded. The procedure was judged to be successful if the pain disappeared and an elevation in the sensation threshold of the lower lip was observed. Adjustment of the IANB device was not required in any patient. A significant elevation in the sensation threshold of the lower lip and the disappearance of pain were observed in all patients. Three of the five patients reported experiencing tongue numbness. Discomfort with the use of the IANB device was less than 30 mm on the visual analog scale. No notable complications were observed. The appropriate type, concentration, and dosage of the local anesthetic must be considered during general dental treatment and oral surgical procedures. Our findings suggest that the IANB device is useful for eliminating errors between operators, enhancing safety, and improving the success rate.
format Online
Article
Text
id pubmed-10504047
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-105040472023-09-16 Clinical Application of Inferior Alveolar Nerve Block Device for Safe and Secure IANB by Any Operator Noguchi, Tomoyasu Odaka, Kento Fukuda, Ken-ichi Pain Res Manag Research Article The inferior alveolar nerve block (IANB) is an established technique with a success rate of 60–80%; however, large errors have been reported among operators. Some dentists do not prefer to use IANB because of the risk of complications. Nevertheless, it is a useful technique for pain control, and a secure IANB offers significant benefits to operators and patients. This case series study aimed to investigate the efficacy of the “IANB Device,” a nerve block guide for IANB, and the adverse events associated with its use in clinical practice. IANB was performed using the device on five patients who had undergone detailed computed tomography examination for chronic orofacial pain in the third division of the trigeminal nerve. Lidocaine 1% (1 mL, no adrenaline added) was used as the local anesthetic. IANB was performed by three dentists with 2, 5, and 11 years of experience in orofacial pain treatment. Thus, the data were collected in triplicate for each patient. The primary endpoints were whether adjustment of the IANB device was required, changes in the sensation threshold of the lower lip, the time to disappearance of pain, the presence or absence of tongue sensation (“Do you have numbness in your tongue?”: “Yes/No”), and discomfort (visual analog scale). The incidence of any other adverse events was recorded. The procedure was judged to be successful if the pain disappeared and an elevation in the sensation threshold of the lower lip was observed. Adjustment of the IANB device was not required in any patient. A significant elevation in the sensation threshold of the lower lip and the disappearance of pain were observed in all patients. Three of the five patients reported experiencing tongue numbness. Discomfort with the use of the IANB device was less than 30 mm on the visual analog scale. No notable complications were observed. The appropriate type, concentration, and dosage of the local anesthetic must be considered during general dental treatment and oral surgical procedures. Our findings suggest that the IANB device is useful for eliminating errors between operators, enhancing safety, and improving the success rate. Hindawi 2023-09-08 /pmc/articles/PMC10504047/ /pubmed/37719895 http://dx.doi.org/10.1155/2023/1021918 Text en Copyright © 2023 Tomoyasu Noguchi et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Noguchi, Tomoyasu
Odaka, Kento
Fukuda, Ken-ichi
Clinical Application of Inferior Alveolar Nerve Block Device for Safe and Secure IANB by Any Operator
title Clinical Application of Inferior Alveolar Nerve Block Device for Safe and Secure IANB by Any Operator
title_full Clinical Application of Inferior Alveolar Nerve Block Device for Safe and Secure IANB by Any Operator
title_fullStr Clinical Application of Inferior Alveolar Nerve Block Device for Safe and Secure IANB by Any Operator
title_full_unstemmed Clinical Application of Inferior Alveolar Nerve Block Device for Safe and Secure IANB by Any Operator
title_short Clinical Application of Inferior Alveolar Nerve Block Device for Safe and Secure IANB by Any Operator
title_sort clinical application of inferior alveolar nerve block device for safe and secure ianb by any operator
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504047/
https://www.ncbi.nlm.nih.gov/pubmed/37719895
http://dx.doi.org/10.1155/2023/1021918
work_keys_str_mv AT noguchitomoyasu clinicalapplicationofinferioralveolarnerveblockdeviceforsafeandsecureianbbyanyoperator
AT odakakento clinicalapplicationofinferioralveolarnerveblockdeviceforsafeandsecureianbbyanyoperator
AT fukudakenichi clinicalapplicationofinferioralveolarnerveblockdeviceforsafeandsecureianbbyanyoperator